Publicacións en colaboración con investigadores/as de Universitat Autònoma de Barcelona (31)

2024

  1. Plasma fibrinogen and risk of vascular recurrence after ischaemic stroke: An individual participant and summary-level data meta-analysis of 11 prospective studies

    European Stroke Journal, Vol. 9, Núm. 3, pp. 704-713

  2. Sex-Stratified Genome-Wide Association Study in the Spanish Population Identifies a Novel Locus for Lacunar Stroke

    Stroke, Vol. 55, Núm. 10, pp. 2462-2471

2023

  1. C-Reactive Protein, Interleukin-6, and Vascular Recurrence After Stroke: An Individual Participant Data Meta-Analysis

    Stroke, Vol. 54, Núm. 5, pp. 1289-1299

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  3. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

  4. Unraveling the potential of endothelial progenitor cells as a treatment following ischemic stroke

    Frontiers in Neurology, Vol. 13

2021

  1. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

2020

  1. Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome

    Brain Communications, Vol. 2, Núm. 2

2019

  1. Genome-wide association study of white blood cell counts in patients with ischemic stroke

    Stroke, Vol. 50, Núm. 12, pp. 3618-3621

2014

  1. In vivo theranostics at the peri-infarct region in cerebral ischemia

    Theranostics, Vol. 4, Núm. 1, pp. 90-105

  2. Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: A systematic review and meta-analysis

    Journal of Neuroimmunology, Vol. 274, Núm. 1-2, pp. 215-224

  3. Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia

    Journal of Cellular and Molecular Medicine, Vol. 18, Núm. 8, pp. 1571-1579

2011

  1. Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke

    Journal of Translational Medicine, Vol. 9

  2. The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome

    Thrombosis and Haemostasis, Vol. 105, Núm. 3, pp. 421-429

2010

  1. Association of growth factors with arterial recanalization and clinical outcome in patients with ischemic stroke treated with tPA

    Journal of Thrombosis and Haemostasis, Vol. 8, Núm. 7, pp. 1567-1574

  2. Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: How well are we correcting it?: Implications for outcome

    Stroke, Vol. 41, Núm. 10, pp. 2362-2365

  3. The effect of simvastatin on the proteome of detergent-resistant membrane domains: Decreases of specific proteins previously related to cytoskeleton regulation, calcium homeostasis and cell fate

    Proteomics, Vol. 10, Núm. 10, pp. 1954-1965

2009

  1. High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage

    Journal of Cerebral Blood Flow and Metabolism, Vol. 29, Núm. 12, pp. 1968-1974